{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:56:01Z","timestamp":1785772561306,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fluid management in patent ductus arteriosus (PDA) treatment is debated, with fluid restriction traditionally used to promote closure, though its impact on outcomes is uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retro-prospective cohort single-center study compared two cohorts of preterm neonates receiving pharmacological treatment for hemodynamically significant PDA (hsPDA). The 2021\u20132023 cohort followed an updated, higher fluid intake protocol based on neonatal weight and day of life (80\u2013100\u2009ml\/kg\/day for extreme preterm &lt;1000\u2009g on day 1), while the 2018\u20132020 cohort adhered to a more restrictive approach based on gestational age and day of life (70\u2009ml\/kg\/day for extreme preterm \u226426 weeks on day 1) and fluid restriction from 5 to 20% during pharmacological treatment of hsPDA. Outcomes included PDA closure rates, growth parameters, and neonatal complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>hsPDA closure rates and major complications (intraventricular hemorrhage, necrotizing enterocolitis, or chronic lung disease) were similar between groups. However, fluid-restricted neonates required more central catheter days, longer times to full enteral feeding, and had poorer growth at discharge (lower weight z-scores).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fluid restriction during pharmacological PDA treatment may adversely affect growth and clinical care without improving closure rates. A balanced, individualized fluid management strategy could enhance neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The article suggests that fluid restriction does not improve the response to pharmacological treatment for PDA, but could negatively influence growth of preterm infants before discharge, which might have long term repercussions.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>It highlights there is no benefit, but potential harm, of fluid restriction to promote PDA in this vulnerable population.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The findings could guide changes in clinical practice, improving PDA management and potentially reducing complications for preterm infants who are highly sensitive to fluid imbalances.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The study advocates for further clinical trials to explore the optimal hydration strategies in managing PDA, paving the way for future research that can refine and standardize treatment protocols.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04497-w","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:07:28Z","timestamp":1761541648000},"page":"2320-2326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Standard versus restricted fluid administration in preterm infants undergoing pharmacological treatment for haemodynamically significant patent ductus arteriosus"],"prefix":"10.1038","volume":"99","author":[{"given":"Angela","family":"Paladini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Prontera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velia","family":"Purcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Vanina","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.earlhumdev.2008.12.008","volume":"85","author":"A Chiruvolu","year":"2009","unstructured":"Chiruvolu, A., Punjwani, P. & Ramaciotti, C. Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates. Early Hum. Dev. 85, 147\u2013149 (2009).","journal-title":"Early Hum. Dev."},{"key":"4497_CR2","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1136\/archdischild-2014-306339","volume":"100","author":"A Rolland","year":"2015","unstructured":"Rolland, A., Shankar-Aguilera, S., Diomand\u00e9, D., Zupan-Simunek, V. & Boileau, P. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch. Dis. Child Fetal Neonatal Ed. 100, F55\u2013F58 (2015).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"4497_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/ANC.0000000000000340","volume":"17","author":"S Prescott","year":"2017","unstructured":"Prescott, S. & Keim-Malpass, J. Patent ductus arteriosus in the preterm infant: diagnostic and treatment options. Adv. Neonatal Care, Adv. Neonatal Care 17, 10\u201318 (2017).","journal-title":"Adv. Neonatal Care, Adv. Neonatal Care"},{"key":"4497_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra, S. et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319, 1221\u20131238 (2018).","journal-title":"JAMA"},{"key":"4497_CR5","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00431-022-04441-8","volume":"181","author":"T Hundscheid","year":"2022","unstructured":"Hundscheid, T., El-Khuffash, A., McNamara, P. J. & de Boode, W. P. Survey highlighting the lack of consensus on diagnosis and treatment of patent ductus arteriosus in prematurity. Eur. J. Pediatr. 181, 2459\u20132468 (2022).","journal-title":"Eur. J. Pediatr."},{"key":"4497_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1056\/NEJM198003133021103","volume":"302","author":"EF Bell","year":"1980","unstructured":"Bell, E. F., Warburton, D., Stonestreet, B. S. & Oh, W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N. Engl. J. Med. 302, 598\u2013604 (1980).","journal-title":"N. Engl. J. Med."},{"key":"4497_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jp.7211895","volume":"28","author":"BE Stephens","year":"2008","unstructured":"Stephens, B. E. et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J. Perinatol. 28, 123\u2013128 (2008).","journal-title":"J. Perinatol."},{"key":"4497_CR8","volume":"2014","author":"EF Bell","year":"2014","unstructured":"Bell, E. F. & Acarregui, M. J. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants: review. Cochrane Database Syst. Rev. 2014, CD000503 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4497_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00431-022-04685-4","volume":"182","author":"G Francescato","year":"2023","unstructured":"Francescato, G. et al. Fluid restriction in the management of patent ductus arteriosus in Italy: a nationwide survey. Eur. J. Pediatr. 182, 393\u2013401 (2023).","journal-title":"Eur. J. Pediatr."},{"key":"4497_CR10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.clnu.2018.06.948","volume":"37","author":"F Jochum","year":"2018","unstructured":"Jochum, F. et al. ESPGHAN\/ESPEN\/ESPR guidelines on pediatric parenteral nutrition: fluid and electrolytes. Clin. Nutr. 37, 2344\u20132353 (2018).","journal-title":"Clin. Nutr."},{"key":"4497_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LS Papile","year":"1978","unstructured":"Papile, L. S., Burstein, J., Burstein, R. & Keffler, H. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants weighing less than 1500 grams. J. Pediatr. 92, 529\u2013534 (1978).","journal-title":"J. Pediatr."},{"key":"4497_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-4328(05)80189-5","volume":"49","author":"LS De Vries","year":"1992","unstructured":"De Vries, L. S., Eken, P. & Dubowitz, L. M. The spectrum of leukomalacia using cranial ultrasound. s. Behav. Brain Res. 49, 1\u20136 (1992).","journal-title":"s. Behav. Brain Res."},{"key":"4497_CR13","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch. Ophthalmol. 128, E51\u2013E68 (2005)."},{"key":"4497_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell, M. J. et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann. Surg. 187, 1\u20137 (1978).","journal-title":"Ann. Surg."},{"key":"4497_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41390-018-0077-x","volume":"84","author":"D van Laere","year":"2018","unstructured":"van Laere, D. et al. Application of NPE in the assessment of a patent ductus arteriosus. Pediatr. Res. 84, 46\u201356 (2018).","journal-title":"Pediatr. Res."},{"key":"4497_CR16","doi-asserted-by":"publisher","first-page":"573627","DOI":"10.3389\/fped.2020.573627","volume":"8","author":"Y Singh","year":"2020","unstructured":"Singh, Y., Fraisse, A., Erdeve, O. & Atasay, B. Echocardiographic diagnosis and hemodynamic evaluation of patent ductus arteriosus in extremely low gestational age newborn infants. Front. Pediatr. 8, 573627 (2020).","journal-title":"Front. Pediatr."},{"key":"4497_CR17","first-page":"CD013278","volume":"12","author":"S Mitra","year":"2020","unstructured":"Mitra, S., Scrivens, A., von Kursell, A. M. & Disher, T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants: review. Cochrane Database Syst. Rev. 12, CD013278 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4497_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41372-019-0347-4","volume":"39","author":"M Liebowitz","year":"2019","unstructured":"Liebowitz, M. et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J. Perinatol. 39, 599\u2013607 (2019).","journal-title":"J. Perinatol."},{"key":"4497_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jpeds.2007.04.058","volume":"151","author":"T Rakza","year":"2007","unstructured":"Rakza, T. et al. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. J. Pediatr. 151, 624\u2013628 (2007).","journal-title":"J. Pediatr."},{"key":"4497_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/adc.67.10_Spec_No.1169","volume":"67","author":"N Evans","year":"1992","unstructured":"Evans, N. & Moorcraft, J. Effect of patency of ductus arteriosus on blood pressure in very preterm infants. Arch. Dis. Child. 67, 1169\u20131173 (1992).","journal-title":"Arch. Dis. Child."},{"key":"4497_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mpd.2000.106569","volume":"137","author":"M Kluckow","year":"2000","unstructured":"Kluckow, M. & Evans, N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J. Pediatr. 137, 68\u201372 (2000).","journal-title":"J. Pediatr."},{"key":"4497_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1469-8749.1990.tb16957.x","volume":"32","author":"DB Shortland","year":"1990","unstructured":"Shortland, D. B. et al. Patent ductus arteriosus and cerebral circulation in preterm infants. Dev. Med. Child Neurol. 32, 386\u2013393 (1990).","journal-title":"Dev. Med. Child Neurol."},{"key":"4497_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0022-3476(94)70210-1","volume":"125","author":"S Shimada","year":"1994","unstructured":"Shimada, S., Kasai, T., Konishi, M. & Fujiwara, T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J. Pediatr. 125, 270\u2013277 (1994).","journal-title":"J. Pediatr."},{"key":"4497_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.pedneo.2020.05.011","volume":"61","author":"YH Wu","year":"2020","unstructured":"Wu, Y. H. et al. Differential determinants of patent ductus arteriosus closure for prematurity of varying birth body weight: a retrospective cohort study. Pediatr. Neonatol. 61, 513\u2013521 (2020).","journal-title":"Pediatr. Neonatol."},{"key":"4497_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/ANC.0000000000000590","volume":"19","author":"C Conrad","year":"2019","unstructured":"Conrad, C. & Desi Newberry, D. Hemodynamic effects of fluid restriction in preterm infants with significant PDA. Adv. Neonatal Care 19, 179\u2013187 (2019).","journal-title":"Adv. Neonatal Care"},{"key":"4497_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/apa.14815","volume":"108","author":"L Hansson","year":"2019","unstructured":"Hansson, L., Lind, T., Wiklund, U., \u00d6hlund, I. & Rydberg, A. Fluid restriction negatively affects energy intake and growth in very low birthweight infants with hemodynamically significant patent ductus arteriosus. Acta Paediatr. 108, 1985\u20131992 (2019).","journal-title":"Acta Paediatr."},{"key":"4497_CR27","doi-asserted-by":"publisher","unstructured":"Lembo, C., El-Khuffash, A., Fusch, C., Iacobelli, S. & Lapillonne, A. ESPR Nutrition council members. Nutrition of the preterm infant with persistent ductus arteriosus: existing evidence and practical implications. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-023-02754-4 (2023).","DOI":"10.1038\/s41390-023-02754-4"},{"key":"4497_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00431-020-03796-0","volume":"180","author":"YJ Kim","year":"2021","unstructured":"Kim, Y. J., Shin, S. H. & Cho, H. Extrauterine growth restriction in extremely preterm infants based on the Intergrowth-21st Project Preterm Postnatal Follow-up Study growth charts and the Fenton growth charts. Eur. J. Pediatr. 180, 817\u2013824 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"4497_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41372-021-00948-4","volume":"41","author":"K Makker","year":"2021","unstructured":"Makker, K., Ji, Y., Hong, X. & Wang, X. Antenatal and neonatal factors contributing to extrauterine growth failure (EUGR) among preterm infants in Boston Birth Cohort (BBC). J. Perinatol. 41, 1025\u20131032 (2021).","journal-title":"J. Perinatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04497-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:20:31Z","timestamp":1785770431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04497-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04497-w","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ethics Committee of Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma\u2014Universit\u00e0 Cattolica del Sacro Cuore (ID 4798). Written informed consent was obtained from parents. The study was conducted in accordance with the World Medical Association Declaration of Helsinki for medical research involving human subjects. Data are available from the Department of women\u2019s health, child health and public health sciences of Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma\u2014Universit\u00e0 Cattolica del Sacro Cuore.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent was obtained from all parents of participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}